Body Plethysmography

Body Plethysmography Market Outlook

The global body plethysmography market was valued at approximately USD 390 million in 2023 and is projected to reach around USD 634 million by 2035, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period. This growth can be attributed to the rising prevalence of respiratory and cardiovascular diseases, an increasing geriatric population, and advancements in technology that enhance the accuracy and usability of plethysmography devices. Additionally, the growing emphasis on preventive healthcare and the need for early diagnosis are further propelling the demand for plethysmography systems across various healthcare settings. The expansion of healthcare infrastructures, coupled with a surge in research and development activities in the medical devices sector, significantly contributes to the market's progressive outlook.

Growth Factor of the Market

The body plethysmography market is primarily driven by the increasing incidence of chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), and congenital heart disease, which necessitate precise and comprehensive diagnostic tests. The technological advancements in plethysmography devices, including the integration of digital technologies and software solutions, have improved data collection and analysis, thereby boosting their adoption in clinical practice. Furthermore, the growing emphasis on non-invasive testing methods is encouraging healthcare professionals to implement plethysmography as a safe and efficient diagnostic tool. The rise in healthcare expenditure globally, especially in developing countries, fosters the expansion of medical facilities, which in turn enhances the accessibility of plethysmography tests. Lastly, the increasing awareness regarding the significance of early diagnosis among the population is promoting the utilization of plethysmography devices in routine health assessments.

Key Highlights of the Market

• The global body plethysmography market is expected to experience a CAGR of 5.2% from 2023 to 2035.
• Technological advancements in plethysmography devices are significantly enhancing diagnostic capabilities.
• The increasing prevalence of respiratory and cardiovascular diseases is a major driving factor for the market.
• Rising healthcare expenditure, particularly in emerging markets, is fostering market growth.
• Non-invasive nature of plethysmography tests is boosting their adoption in clinical settings.

By Product Type

Whole Body Plethysmography:

Whole body plethysmography is a comprehensive testing method used to assess lung volumes and airway resistance. It is particularly effective in diagnosing and managing pulmonary diseases such as asthma, COPD, and restrictive lung disorders. This type of plethysmography provides detailed insights into lung function by measuring how much air the lungs can hold, offering valuable data for treatment planning and monitoring disease progression. The increasing prevalence of lung conditions is driving the demand for whole body plethysmography, making it a significant segment of the market. Furthermore, advancements in technology have improved the efficiency and accuracy of these devices, enhancing their attractiveness among healthcare providers.

Respiratory Plethysmography:

Respiratory plethysmography focuses specifically on measuring the changes in the thoracic cavity during breathing. This method is essential for evaluating respiratory mechanics and identifying abnormalities in lung function. It is widely used in pulmonary function tests and is increasingly being incorporated into sleep studies to assess conditions such as sleep apnea. The growing awareness of respiratory health, coupled with rising cases of respiratory diseases, has bolstered the adoption of respiratory plethysmography. Additionally, advancements in sensor technology have enhanced the precision and reliability of measurements, further contributing to market growth.

Penile Plethysmography:

Penile plethysmography is a specialized technique used primarily in the assessment of male sexual arousal and function. It involves measuring changes in penile volume and is often employed in clinical settings for the diagnosis of erectile dysfunction and other sexual disorders. The increasing prevalence of such conditions and the growing awareness of sexual health among the male population are driving the demand for penile plethysmography. Moreover, the integration of advanced technology has improved the comfort and accuracy of these tests, making them more acceptable to patients and healthcare providers alike.

Oral Volume Plethysmography:

Oral volume plethysmography is utilized primarily in the assessment of airway resistance and lung function, especially in sleep studies. By measuring the volume of air exhaled and inhaled during respiration, this technique assists in diagnosing conditions like sleep apnea and other breathing-related disorders. The growing incidence of sleep-related health issues, combined with an increasing focus on sleep medicine, is propelling the demand for oral volume plethysmography. Furthermore, the non-invasive nature of this method enhances patient compliance, thereby contributing to its market growth.

Others:

This category encompasses various other plethysmography techniques that cater to specific diagnostic needs. These may include technologies that combine plethysmography with imaging or other diagnostic modalities. The diversification of plethysmography methods is driven by the need for tailored solutions that address unique clinical challenges, enhancing the overall efficiency of diagnostic processes. As healthcare continues to evolve, the demand for innovative and specialized plethysmography techniques is expected to rise, thereby influencing the growth of this segment.

By Application

Pulmonary Function Testing:

Pulmonary function testing (PFT) is one of the primary applications of plethysmography, providing critical data on lung capacity and airflow. This testing is essential for diagnosing and managing various pulmonary disorders, including asthma and COPD. The rising incidence of these diseases, coupled with an increasing emphasis on preventive healthcare and early diagnosis, is driving the demand for pulmonary function testing services. Moreover, advancements in plethysmography technology have improved the accuracy and efficiency of these tests, making them indispensable in respiratory medicine. As healthcare providers seek more effective ways to monitor and manage lung health, the PFT application will continue to expand its footprint in the market.

Cardiac Output Measurement:

Plethysmography is also employed in cardiac output measurement, providing essential insights into cardiovascular health. By assessing blood volume changes, this application allows healthcare professionals to evaluate heart function and detect abnormalities. With the growing prevalence of cardiovascular diseases globally, the market for cardiac output measurement is on the rise. Enhanced precision in monitoring and diagnosis is further bolstering the adoption of plethysmography for this purpose. The demand for non-invasive cardiac monitoring techniques is increasing, which is likely to drive the growth of this segment in the forthcoming years.

Body Composition Analysis:

Body composition analysis is another significant application of plethysmography, particularly in fitness and weight management. This technique provides insights into fat mass, lean mass, and overall body composition, thus helping individuals and healthcare professionals make informed decisions regarding health and fitness. The rising awareness of obesity and its associated health risks has led to an increased demand for body composition analysis solutions. Furthermore, as the fitness industry continues to evolve, the integration of plethysmography into routine assessments is expected to gain traction, providing a solid growth avenue for this application.

Sleep Apnea Diagnosis:

Plethysmography plays a vital role in diagnosing sleep apnea by measuring respiratory patterns and detecting abnormalities during sleep. The growing prevalence of sleep disorders, particularly sleep apnea, is propelling the demand for diagnostic tools that can accurately assess these conditions. As awareness regarding sleep health increases, more individuals are seeking diagnostic testing, which is driving market growth. Moreover, technological advancements in the field enable more accurate and comfortable assessments for patients, further enhancing the appeal of plethysmography in sleep medicine.

Others:

This category includes various other applications of plethysmography, such as monitoring peripheral circulation and assessing vascular health. The adaptability of plethysmography technology allows it to cater to a wide range of diagnostic needs, making it a versatile tool in clinical settings. As healthcare systems continue to innovate and expand, the demand for plethysmography in diverse applications is expected to grow, providing additional opportunities for market development.

By Distribution Channel

Hospitals:

Hospitals are the primary distribution channel for plethysmography devices, given their extensive patient care services and diagnostic capabilities. The integration of advanced diagnostic technologies within hospitals enhances patient outcomes and facilitates comprehensive care. Hospitals typically have the infrastructure to support the installation and operation of plethysmography devices, making them a key market segment. Additionally, the growing focus on accurate and timely diagnosis in hospital settings drives the demand for plethysmography equipment, further solidifying this channel's significance in the market.

Clinics:

Clinics, particularly specialized pulmonary and cardiology clinics, represent a crucial distribution channel for plethysmography devices. These facilities often employ plethysmography in conjunction with other diagnostic tools to provide a holistic assessment of patient health. The increasing trend of outpatient care and the rising number of specialized clinics are driving the growth of this distribution channel. Moreover, the ability to offer non-invasive testing options makes plethysmography an attractive choice for clinics seeking to enhance their diagnostic offerings.

Diagnostic Centers:

Diagnostic centers play a pivotal role in the distribution of plethysmography devices, focusing primarily on specialized testing and assessments. These centers are equipped with advanced technology and skilled professionals who can perform plethysmography with high accuracy. The rise in patient referrals for diagnostic testing, coupled with the need for efficient and reliable services, is propelling the demand for plethysmography in diagnostic centers. As the healthcare landscape evolves, diagnostic centers are expected to increasingly integrate plethysmography into their services, further driving market growth.

Research Institutes:

Research institutes represent an important distribution channel for plethysmography as they conduct extensive studies and trials to advance medical knowledge. These institutions utilize plethysmography for research purposes, particularly in studies related to respiratory and cardiovascular health. The collaboration between research institutes and healthcare providers fosters innovation in plethysmography technology, contributing to improved diagnostic methods. Moreover, the focus on research and development in the medical field enhances the demand for plethysmography in research settings, offering significant growth potential.

Others:

The others segment encompasses various alternative distribution channels, including home healthcare settings and telemedicine platforms. The increasing trend of at-home health monitoring and the integration of telehealth services are driving the demand for portable and user-friendly plethysmography devices. This shift in distribution channels allows for greater accessibility and convenience for patients, further fueling market growth. As healthcare continues to evolve and prioritize patient-centric solutions, the demand for plethysmography in alternative settings is expected to rise.

By Technology Type

Impedance Plethysmography:

Impedance plethysmography is a non-invasive technique that measures changes in electrical impedance to assess blood flow and volume. This method is widely used in various clinical applications, including cardiac monitoring and vascular health assessments. The increasing emphasis on non-invasive diagnostic techniques is driving the demand for impedance plethysmography, as it provides accurate and real-time data without the need for invasive procedures. The growing prevalence of cardiovascular diseases further boosts the adoption of this technology, positioning it as a significant segment of the plethysmography market.

Optical Plethysmography:

Optical plethysmography utilizes light to assess changes in blood volume within tissues, making it a valuable tool for monitoring peripheral circulation and vascular health. This technology is gaining traction due to its non-invasive nature and the ease of use in various clinical settings. The rising awareness of vascular conditions and the need for continuous monitoring are driving the demand for optical plethysmography solutions. Additionally, advancements in sensor technology are enhancing the accuracy and reliability of measurements, further contributing to market growth.

Air Displacement Plethysmography:

Air displacement plethysmography is a highly accurate method used for body composition analysis by measuring air displacement in a closed chamber. This technique is particularly popular in fitness and research applications, offering precise assessments of fat and lean mass. The growing awareness of obesity and related health risks is driving the demand for air displacement plethysmography, as it provides valuable insights for weight management and health optimization. With technological advancements improving the efficiency and user experience of these devices, this segment is expected to witness significant growth.

Volume Plethysmography:

Volume plethysmography is a technique that measures changes in volume within a specific region of the body, typically used to assess organ function and blood flow. This method is crucial for diagnosing various medical conditions and monitoring treatment efficacy. The increasing reliance on non-invasive diagnostic tools in clinical practice is propelling the demand for volume plethysmography. Furthermore, the integration of advanced technology has improved the accuracy and comfort of these tests, enhancing their appeal to healthcare providers and patients alike.

Others:

The others segment of technology type includes various emerging and specialized plethysmography techniques that cater to specific clinical needs. As research and development in medical technology continue to advance, new plethysmography methods are likely to emerge, enhancing the overall diagnostic landscape. The diversification of technology types allows for a broader range of applications and increased adaptability in clinical settings, positioning this segment for continued growth in the coming years.

By Region

The North American region holds the largest share of the body plethysmography market, accounting for approximately 39% of the global market value in 2023. The region benefits from advanced healthcare infrastructure, high healthcare expenditure, and a growing prevalence of chronic diseases, particularly respiratory and cardiovascular conditions. Furthermore, the presence of key market players and a focus on research and development activities in the United States and Canada significantly contribute to the market's expansion. The projected CAGR for the North American body plethysmography market is estimated to be around 5.0% during the forecast period, indicating robust growth potential.

Europe ranks as the second-largest market for body plethysmography, capturing a market share of around 31% in 2023. The region is experiencing a rise in respiratory and cardiovascular diseases, coupled with an increasing emphasis on preventive healthcare measures. The European healthcare system's focus on innovative diagnostic solutions drives the demand for advanced plethysmography devices. The expected CAGR for the European market is approximately 4.8%, reflecting a strong inclination toward the adoption of plethysmography technology within the healthcare sector. Meanwhile, the Asia Pacific region is witnessing significant growth, projected to expand at a CAGR of 6.5% during the same period, driven by rising healthcare investments and an increasing population seeking improved health services.

Opportunities

One of the most promising opportunities for the body plethysmography market lies in the growing emphasis on preventive healthcare and early diagnosis. As awareness regarding health issues increases, more individuals are seeking regular health check-ups and diagnostic testing. This trend is likely to boost the adoption of plethysmography devices across various healthcare settings, including hospitals, clinics, and diagnostic centers. Additionally, technological advancements that enhance the functionality and user-friendliness of plethysmography devices present significant opportunities for market players. Investing in research and development to innovate and produce next-generation plethysmography devices could position companies favorably in a competitive landscape.

Moreover, the rising prevalence of chronic diseases such as asthma, COPD, and cardiovascular conditions provides a substantial growth opportunity for the body plethysmography market. As the population ages and the incidence of these diseases increases, healthcare providers will seek advanced diagnostic solutions to improve patient outcomes. This growing demand will necessitate the availability of a wide range of plethysmography options, catering to various clinical needs. Furthermore, the expansion of telemedicine and home healthcare services opens new avenues for plethysmography devices, allowing patients to access diagnostic testing from the comfort of their homes. By capitalizing on these trends, market players can enhance their growth potential and reach a broader customer base.

Threats

Despite the opportunities present in the body plethysmography market, there are several threats that could hinder growth. One significant challenge is the rapid pace of technological advancements, which can lead to the obsolescence of existing products if companies fail to innovate consistently. As competitors introduce newer, more advanced devices, established players must adapt quickly to maintain their market position. Additionally, the high costs associated with advanced plethysmography technology may limit accessibility for smaller healthcare providers and facilities, potentially restricting market growth. Another concern is the regulatory environment, as stringent regulations regarding medical devices can slow down product development and approval processes, impacting time-to-market for new innovations.

Furthermore, the increasing trend of consolidation within the healthcare industry may pose a threat to smaller companies in the body plethysmography market. As larger healthcare organizations acquire smaller entities, the competitive landscape may shift, leading to fewer options for customers and potentially stifling innovation. The market may also face challenges related to reimbursement policies, as changes in healthcare legislation and insurance coverage can affect the affordability and accessibility of plethysmography services. Addressing these threats will require strategic planning and adaptability from market players to ensure sustainable growth and competitiveness.

Competitor Outlook

• CareFusion Corporation
• Vyaire Medical, Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• Schiller AG
• Nihon Kohden Corporation
• GE Healthcare
• Drägerwerk AG & Co. KGaA
• Smiths Medical
• Fukuda Denshi Co., Ltd.
• Omron Healthcare, Inc.
• Bioreactants Ltd.
• Cosmed Srl
• Hiller GmbH
• Innovision Healthcare

The competitive landscape of the body plethysmography market is characterized by the presence of several key players, each striving to enhance their market position through innovation and strategic partnerships. Major companies are focusing on research and development to introduce advanced plethysmography technologies that cater to evolving healthcare needs. Moreover, partnerships and collaborations with healthcare providers and research institutions are becoming increasingly common, enabling companies to access new market segments and expand their product offerings. The emphasis on product differentiation and customer-centric solutions is driving competition, as companies seek to enhance user experience and improve patient outcomes in diagnostic testing.

CareFusion Corporation is one of the leading players in the body plethysmography market, known for its innovative health solutions and commitment to improving patient care. The company offers a range of plethysmography devices that are widely used in hospitals and clinics for accurate respiratory assessment. Vyaire Medical, Inc. is another significant competitor, specializing in respiratory diagnostics and critical care solutions. With a focus on enhancing respiratory health, Vyaire’s advanced plethysmography systems are designed to provide healthcare professionals with comprehensive and reliable data for informed decision-making. Both companies are actively engaging in partnerships and collaborations to expand their reach and enhance product development.

Koninklijke Philips N.V. plays a crucial role in the body plethysmography market with its innovative healthcare technologies. The company's commitment to integrating advanced technology into diagnostic tools has led to the development of user-friendly and efficient plethysmography devices. Moreover, GE Healthcare is recognized for its extensive portfolio of medical technologies, including plethysmography solutions that cater to various healthcare settings. The company is dedicated to enhancing diagnostic accuracy and patient care through continuous innovation and strategic investments in research and development. These companies, among others, are poised to shape the future of the body plethysmography market through their commitment to excellence and innovation.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cosmed Srl
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Hiller GmbH
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Schiller AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GE Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smiths Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Bioreactants Ltd.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Vyaire Medical, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Innovision Healthcare
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 CareFusion Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Omron Healthcare, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Fukuda Denshi Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Koninklijke Philips N.V.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Nihon Kohden Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Drägerwerk AG & Co. KGaA
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Body Plethysmography Market, By Application
    • 6.1.1 Pulmonary Function Testing
    • 6.1.2 Cardiac Output Measurement
    • 6.1.3 Body Composition Analysis
    • 6.1.4 Sleep Apnea Diagnosis
    • 6.1.5 Others
  • 6.2 Body Plethysmography Market, By Product Type
    • 6.2.1 Whole Body Plethysmography
    • 6.2.2 Respiratory Plethysmography
    • 6.2.3 Penile Plethysmography
    • 6.2.4 Oral Volume Plethysmography
    • 6.2.5 Others
  • 6.3 Body Plethysmography Market, By Technology Type
    • 6.3.1 Impedance Plethysmography
    • 6.3.2 Optical Plethysmography
    • 6.3.3 Air Displacement Plethysmography
    • 6.3.4 Volume Plethysmography
    • 6.3.5 Others
  • 6.4 Body Plethysmography Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Diagnostic Centers
    • 6.4.4 Research Institutes
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Body Plethysmography Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Body Plethysmography market is categorized based on

By Product Type

• Whole Body Plethysmography
• Respiratory Plethysmography
• Penile Plethysmography
• Oral Volume Plethysmography
• Others

By Application

• Pulmonary Function Testing
• Cardiac Output Measurement
• Body Composition Analysis
• Sleep Apnea Diagnosis
• Others

By Distribution Channel

• Hospitals
• Clinics
• Diagnostic Centers
• Research Institutes
• Others

By Technology Type

• Impedance Plethysmography
• Optical Plethysmography
• Air Displacement Plethysmography
• Volume Plethysmography
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• CareFusion Corporation
• Vyaire Medical, Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• Schiller AG
• Nihon Kohden Corporation
• GE Healthcare
• Drägerwerk AG & Co. KGaA
• Smiths Medical
• Fukuda Denshi Co., Ltd.
• Omron Healthcare, Inc.
• Bioreactants Ltd.
• Cosmed Srl
• Hiller GmbH
• Innovision Healthcare